secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001606498-24-000055
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical reports Q1 2024 results; key figures not available in 8-K
------------------------------------------------------------------------

- Company announced results for three months ended March 31, 2024.
- No specific EPS, revenue, or guidance figures included in filing text or exhibit.
- Investors should refer to the full press release for detailed financial data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649824000055/0001606498-24-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649824000055/avns-20240502.htm
  HTML page:      https://secwatch.observer/filing/0001606498-24-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer